NUMYTRIS Trademark

Trademark Overview


On Friday, October 13, 2023, a trademark application was filed for NUMYTRIS with the United States Patent and Trademark Office. The USPTO has given the NUMYTRIS trademark a serial number of 98222595. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 20, 2024. This trademark is owned by Acadia Pharmaceuticals, Inc.. The NUMYTRIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related metabolic and neurodevelopmental disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders
numytris

General Information


Serial Number98222595
Word MarkNUMYTRIS
Filing DateFriday, October 13, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2024

Trademark Statements


Goods and ServicesPharmaceutical products and preparations for the treatment of Prader-Willi syndrome (PWS) and related metabolic and neurodevelopmental disorders; pharmaceutical products and preparations for the treatment of neurodevelopmental and metabolic disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcadia Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameAcadia Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Friday, May 31, 2024NON-FINAL ACTION WRITTEN
Friday, May 31, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 31, 2024NON-FINAL ACTION E-MAILED
Friday, May 31, 2024ASSIGNED TO EXAMINER
Tuesday, October 17, 2023NEW APPLICATION ENTERED
Tuesday, October 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2024EXAMINER'S AMENDMENT ENTERED
Friday, July 12, 2024EXAMINERS AMENDMENT E-MAILED
Friday, July 12, 2024EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 20, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 12, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED